Cargando…
APRIL and BAFF: novel biomarkers for central nervous system lymphoma
BACKGROUND: Early diagnosis of CNS lymphoma (CNSL) is essential for successful therapy of this rapidly progressing brain tumor. However, in patients presenting with focal brain lesions, fast and reliable diagnosis of PCNSL remains a challenge. A proliferation-inducing ligand (APRIL) and B cell activ...
Autores principales: | Mulazzani, Matthias, Huber, Marion, Borchard, Sabine, Langer, Sigrid, Angele, Barbara, Schuh, Elisabeth, Meinl, Edgar, Dreyling, Martin, Birnbaum, Tobias, Straube, Andreas, Koedel, Uwe, von Baumgarten, Louisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792247/ https://www.ncbi.nlm.nih.gov/pubmed/31615554 http://dx.doi.org/10.1186/s13045-019-0796-4 |
Ejemplares similares
-
The Role of BAFF-R Signaling in the Growth of Primary Central Nervous System Lymphoma
por: Zhou, Xiaolan, et al.
Publicado: (2020) -
CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymphoma—Diagnostic, Therapeutic, and Prognostic Relevance
por: Masouris, Ilias, et al.
Publicado: (2021) -
Expression of B-cell activating factor, a proliferating inducing ligand and its receptors in primary central nervous system lymphoma
por: Birnbaum, Tobias, et al.
Publicado: (2013) -
Data for the crystal structure of APRIL–BAFF–BAFF heterotrimer
por: Maskos, Klaus, et al.
Publicado: (2015) -
The BAFF-APRIL System in Cancer
por: Ullah, Md Ashik, et al.
Publicado: (2023)